
Member of the European Parliament · Lithuania ECR
Aurelijus Veryga
MEP for Lithuania · European Conservatives & Reformists · Lietuvos valstiečių ir žaliųjų sąjunga · official EP profile
As of 12 September 2026, Aurelijus Veryga (ECR, Lithuania) has declared 138 lobby meetings this term - rank 147 of 719 MEPs by declared meetings.
That is one of the fuller declaration sheets in the Parliament - 1.6× the average member, and 7 of 81 within European Conservatives & Reformists.
73% of this MEP's declared counterpart entries, including diplomatic and government entries, carry a declared EU Transparency Register link - above the like-for-like raw Parliament-wide share of 51%.
Compare with the rest: search and sort all 719 MEPs, or see every MEP from Lithuania.
Compared with the averages
Transparency this term
Monthly declared meetings (bars) and the share of all counterpart entries carrying a declared Register link, including diplomatic and government entries (line), July 2024 to September 2026. This is the same current-term window as the figures above, beginning 16 July 2024.
Current month, partial through 11 Sep 2026: 7 declared meetings in Sep 2026, 57.1% of all counterpart entries carry a declared Register link. Peak: 12 in Apr 2026.
Busiest month: 12 declared in April 2026. Months with no declared meetings have no Register-share value.
Who Aurelijus Veryga meets most
Counterparts are merged by resolved Transparency Register identity where possible. An entry counts as register-linked above only when the MEP declaration itself carries a Register link.
Where the meetings cluster
Most-met sectors
Health & pharma (70), Public affairs & consultancy (12), Transport & automotive (8)
Meetings by committee topic
Public Health (107), Environment, Climate and Food Safety (30)
Most recent declared meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 9 Sep 2026 | MedTech Europe ↗ | Member | Medical Devices Regulation Revision: Simplification, Patient Safety and Innovation |
| 8 Sep 2026 | Parker & Associates | Member | Preparation of the Round Table on Regulatory Coherence for Europe’s Medical Technologies |
| 8 Sep 2026 | Zimmer Biomet Holdings ↗ | Member | Medical Devices Regulation and the Commission’s Draft Revision Proposal |
| 2 Sep 2026 | Dentons Global Advisors Europe SA ↗ | Member | Improving Breast Cancer Outcomes and Quality of Life |
| 1 Sep 2026 | Acumen Public Affairs ↗ | Member | Organisation of a European Parliament Event on Vascular Health and the EU Safe Hearts Plan |
| 1 Sep 2026 | Testbiotech | Shadow rapporteur | Risks and Regulation of Genetically Modified Microorganisms |
| 1 Sep 2026 | Save Our Seeds | Shadow rapporteur | Risk Assessment and Regulation of Genetically Modified Microorganisms |
| 8 Jul 2026 | W.L. Gore & Associates GmbH ↗ | Member | Revision of the Medical Device Regulation and Access to Medical Technologies |
| 8 Jul 2026 | Hague Corporate Affairs ↗ | Shadow rapporteur | Genetically Modified Microorganisms and the Future of Sustainable Agriculture |
| 7 Jul 2026 | European Alliance for Christian Education | Member | Freedom of Education, Parental Rights and Religious Freedom in Europe |
Show 20 more meetings
| Date | Counterpart | Capacity | Subject |
|---|---|---|---|
| 7 Jul 2026 | Pharmaceutical Group of the European Union ↗ | Member | Cross-Border Healthcare and EU Health Policy |
| 2 Jul 2026 | Environment and Public Health Institute | Rapporteur | Health Preparedness and Crisis Response under the Union Civil Protection Mechanism Regulation |
| 1 Jul 2026 | Association des Constructeurs Européens de Motocycles | Member | Summer Ride |
| 1 Jul 2026 | MEDICINES FOR EUROPE | Member | Biosimilar Medicines, Access to Healthcare and EU Biotech Competitiveness |
| 25 Jun 2026 | Fourtold ↗ | Member | Roundtable Discussion – Prevention that Saves: EU Leadership and National Action on Vaccination |
| 24 Jun 2026 | Bavarian Nordic A/S | Rapporteur | Union Civil Protection Mechanism, Health Emergency Preparedness and Medical Countermeasures |
| 23 Jun 2026 | EU Coalition on Structural Heart Diseases ↗ | Member | Implementation of the EU Safe Hearts Plan and Structural Heart Disease Care |
| 10 Jun 2026 | Shionogi BV | Member | EU Health Security, Critical Medicines and Biotechnology Innovation |
| 10 Jun 2026 | Breakthrough T1D | Member | Exchange of Views on the EU Biotech Act |
| 10 Jun 2026 | Novartis International AG | Member | Biotechnology Innovation, Health Policy and European Competitiveness |
| 8 Jun 2026 | The Economist Newspaper Limited | Member | 11th annual World Cancer Series Europe, Panel "Improving overall health to reduce cancer risk" |
| 4 Jun 2026 | AbbVie | Member | Strengthening Europe's Biotech Ecosystem |
| 4 Jun 2026 | Testbiotech | Shadow rapporteur | EU Policy on Genetically Modified Microorganisms and Biosafety |
| 3 Jun 2026 | International Longevity Centre UK ↗ | Member | Roundtable "Pillars of Prevention: How can immunisation support healthy ageing and prevent NCDs across Europe?" |
| 2 Jun 2026 | European Chronic Disease Alliance (ECDA) | Member | Discussion "Say No to Nicotine" |
| 2 Jun 2026 | Kræftens Bekæmpelse ↗ | Member | Tobacco Control and Cancer Prevention in Europe |
| 7 May 2026 | European Federation of Pharmaceutical Industries and Associations ↗ | Member | Hosting the Conference "Promoting Early Detection for Better Cardiovascular Outcomes: Towards Comprehensive Health Check Programmes Across Europe" |
| 6 May 2026 | Honda Motor Europe ↗ | Member | "Honda Decarbonisation & Sustainable Mobility Showcase" |
| 6 May 2026 | Parker & Associates | Member | Chemical Regulation and Cardiovascular Medical Devices |
| 29 Apr 2026 | Acumen Public Affairs ↗ | Member | Enhancing Public Health and Economic Resilience through Immunisation |
The full record is in the official EP declarations.
Roll-call voting record
Recorded votes only. Parliament held 5,568 roll-call votes while Aurelijus Veryga held the seat, 537 of them the final vote on a text. A member with no vote recorded may have been on parliamentary business, ill, on leave, or present without voting - the published record does not distinguish these and gives no reason. Votes taken by show of hands or by secret ballot are not recorded by name and are absent here.
How they voted on final texts
Share of the 537 final votes held while seated.
With and against the group
On the 465 final texts where more than half of ECR members casting a vote went one way, and Aurelijus Veryga also voted. Groups are not bound to vote together: a Member's mandate is personal and exercised freely, so neither figure is a measure of performance.
Final texts where Aurelijus Veryga differed from the ECR majority
| Date | Text | Their vote | ECR majority |
|---|---|---|---|
| 7 July 2026 | A10-0169/2026 – Matthias Ecke – Motion for a resolution (as a whole) | Abstained | Against |
| 17 June 2026 | A10-0160/2026 – Tomáš Kubín – Commission proposal to the Council | Against | For |
| 16 June 2026 | A10-0147/2026 – Lukas Mandl – Motion for a resolution (as a whole) | Abstained | Against |
| 30 April 2026 | RC-B10-0216/2026 – Motion for a resolution (as a whole) | Abstained | For |
| 29 April 2026 | A10-0087/2026 – Monika Hohlmeier – Motion for a resolution (as a whole) | For | Abstained |
| 29 April 2026 | A10-0050/2026 – Pasquale Tridico – Motion for a resolution (as a whole) | For | Against |
| 12 March 2026 | A10-0015/2026 – Bogdan Rzońca – Motion for a resolution (as a whole) | Against | Abstained |
| 11 March 2026 | A10-0016/2026 – Petras Auštrevičius – Motion for a resolution (as a whole) | For | Abstained |
| 12 February 2026 | RC-B10-0114/2026 – Motion for a resolution (as a whole) | For | Abstained |
| 10 February 2026 | A10-0002/2026 – Johan Van Overtveldt – Motion for a resolution (as a whole) | For | Abstained |
22 further instances are not listed. All roll-call votes.
Unlinked but matchable
31 counterpart entrys in Aurelijus Veryga's declarations appear to match an EU Transparency Register entry without being linked in the declaration:
- “Parker & Associates” - likely Parker & Associates (2 counterpart entrys)
- “Testbiotech” - likely Testbiotech (2 counterpart entrys)
- “AbbVie” - likely AbbVie (1 counterpart entry)
Matching is automated and can be wrong - see how matching works. Linking the register entry is the fix, and it is the MEP office's to make.